Federated Hermes, Inc. Amicus Therapeutics, Inc. Transaction History

Federated Hermes, Inc.

$43.6 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$11.43 - $14.24 $320 - $398	28 New	28 $0
Q3 2023 Nov 13, 2023	SELL	$11.78 - $13.86 $742 - $873	-63 Reduced 50.81%	61 $0
Q2 2023 Aug 14, 2023	SELL	$10.72 - $13.3 $1,168 - $1,449	-109 Reduced 46.78%	124 $1,000
Q1 2023 May 08, 2023	BUY	$10.91 - $13.54 $2,542 - $3,154	233 New	233 $2,000
Q1 2022 May 13, 2022	SELL	$7.89 - $12.48 $1.79 Million - $2.84 Million	-227,192 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$9.82 - $12.44 $2.23 Million - $2.83 Million	227,192 New	227,192 $2.62 Million
Q1 2021 May 13, 2021	SELL	$9.2 - $23.86 $3.58 Million - $9.28 Million	-388,812 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$13.47 - $24.89 $3.27 Million - $6.05 Million	243,047 Added 166.74%	388,812 $8.98 Million
Q3 2020 Nov 12, 2020	BUY	$12.89 - $15.89 $11,691 - $14,412	907 Added 0.63%	145,765 $2.06 Million
Q2 2020 Aug 13, 2020	BUY	$8.86 - $15.69 $1.28 Million - $2.27 Million	144,858 New	144,858 $2.18 Million
Q2 2019 Aug 14, 2019	SELL	$10.96 - $14.4 $9,557 - $12,556	-872 Closed	0 $0
Q1 2019 May 10, 2019	SELL	$10.04 - $13.92 $773 - $1,071	-77 Reduced 8.11%	872 $12,000
Q4 2018 Feb 13, 2019	SELL	$8.38 - $13.44 $3,980 - $6,384	-475 Reduced 33.36%	949 $9,000
Q3 2018 Nov 13, 2018	SELL	$11.6 - $16.54 $1.12 Million - $1.6 Million	-96,607 Reduced 98.55%	1,424 $18,000
Q2 2018 Aug 10, 2018	BUY	$13.13 - $17.09 $1.28 Million - $1.66 Million	97,305 Added 13402.89%	98,031 $1.53 Million
Q1 2018 May 09, 2018	SELL	$13.76 - $17.12 $883,323 - $1.1 Million	-64,195 Reduced 98.88%	726 $11,000
Q4 2017 Feb 14, 2018	SELL	$12.51 - $16.24 $1.94 Million - $2.52 Million	-154,912 Reduced 70.47%	64,921 $0
Q3 2017 Nov 13, 2017	BUY	$11.74 - $15.78 $2.58 Million - $3.47 Million	219,833	219,833 $3.32 Million

Others Institutions Holding FOLD

# of Institutions

312

Shares Held

312M

Call Options Held

516K

Put Options Held

833K

Vanguard Group Inc Valley Forge, PA

28.8M
Shares

$271 Million
0.01% of portfolio
Perceptive Advisors LLC New York, NY

28.1M
Shares

$264 Million
7.83% of portfolio
Black Rock Inc. New York, NY

24.4M
Shares

$229 Million
0.01% of portfolio
Wellington Management Group LLP Boston, MA

24M
Shares

$226 Million
0.05% of portfolio
Avoro Capital Advisors LLC New York, NY

23.2M
Shares

$218 Million
3.72% of portfolio

View Full List

About AMICUS THERAPEUTICS, INC.

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.64B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

More about FOLD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.

Account